# Human Milk Oligosaccharides (HMOs) - Post Marketing Study on Infants (NeHMO)

> **NCT07302477** · NA · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 125 (actual)

## Conditions studied

- Growth
- Tolerance
- Adverse Event

## Interventions

- **OTHER:** HMO Supplemented Infant Formula

## Key facts

- **NCT ID:** NCT07302477
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-29
- **Primary completion:** 2022-12-15
- **Final completion:** 2022-12-15
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07302477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07302477, "Human Milk Oligosaccharides (HMOs) - Post Marketing Study on Infants (NeHMO)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07302477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*